Filing Details

Accession Number:
0001415889-24-023546
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-17 18:14:15
Reporting Period:
2024-09-16
Accepted Time:
2024-09-17 18:14:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1746466 Equillium Inc. EQ Pharmaceutical Preparations (2834) 821554746
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2012180 Penny Tom 2223 Avenida De La Playa, Suite 105
La Jolla CA 92037
Principal Accounting Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-09-16 38,806 $0.85 10,051 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2024.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.83 to $0.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. Includes 15,000 shares acquired by the reporting person under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024.